http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#Head http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#assertion http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#provenance http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#pubinfo http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#assertion http://purl.obolibrary.org/obo/DOID_9352 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_9352 http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB09265 http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#association http://www.w3.org/2000/01/rdf-schema#label adlyxin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus adlyxin is a glucagon like peptide 1 glp 1 receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus 1 limitations of use 1 has not been studied in patients with chronic pancreatitis or a history of unexplained pancreatitis consider other antidiabetic therapies in patients with a history of pancreatitis not for treatment of type 1 diabetes or diabetic ketoacidosis has not been studied in combination with short acting insulin has not been studied in patients with gastroparesis and is not recommended in patients with gastroparesis limitations of use adlyxin has not been studied in patients with chronic pancreatitis or a history of unexplained pancreatitis consider other antidiabetic therapies in patients with a history of pancreatitis see warnings and precautions 5 2 adlyxin is not a substitute for insulin adlyxin is not indicated for use in patients with type 1 diabetes mellitus or for treatment of diabetic ketoacidosis the concurrent use of adlyxin with short acting insulin has not been studied and is not recommended adlyxin has not been studied in patients with gastroparesis and is not recommended in patients with gastroparesis http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB09265 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#provenance http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#pubinfo http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#sig http://purl.org/nanopub/x/hasSignature Msk+Jx9xoiZCmiVzTmCkoc9R3Bdc7yLFJrrflF7Zq9JyHSlazXOz/AUj64hCqv0+VHKkU6AMbhgdxKdd6dE2zNLWIbH5O+Y31KjBaEMUz13y0uu78RIEFCx4OibXuPXNXp1QPgF/M81gnjZuYHlU9RcmsPewq4I4uQfw+bgGxiA= http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg http://purl.org/dc/terms/created 2021-07-03T14:40:18.947+02:00 http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs